Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-Analysis
Posted
March 9, 2023
Arthritis Care & Research. Vol. 75, No. 2, February 2023, pp 260–271. DOI 10.1002/acr.24784 Abstract: Objective. To determine the risk of recurrent or new malignancy… Read More
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Posted
May 6, 2022
Citation: Kim ST, Chu Y, Misoi M, Suarez-Almazor ME, Tayar JH, Lu H, Buni M, Kramer J, Rodriguez E, Hussain Z, Neelapu SS, Wang J,… Read More
Tumor necrosis factor alpha neutralization attenuates immune checkpoint inhibitor- induced activation of intermediate monocytes in synovial fuid mononuclear cells from patients with infammatory arthritis
Posted
February 16, 2022
Citation: Sørensen AS, Andersen MN, Juul-Madsen K, Broksø AD, Skejø C, Schmidt H, Vorup-Jensen T, Kragstrup TW. Tumor necrosis factor alpha neutralization attenuates immune checkpoint… Read More
Predictors of rheumatic immune-related adverse events and de novo inflammatory arthritis after immune checkpoint inhibitor treatment for cancer
Posted
October 21, 2021
Case-control study identifying predictors of rheumatic toxicities and ICI-inflammatory arthritis. Read More
TNF in the era of immune checkpoint inhibitors: friend or foe?
Posted
July 9, 2021
Review of clinical and preclinical studies that address the relationship between TNF, TNF inhibition and cancer. Read More
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease
Posted
January 21, 2021
Melanoma patients with preexisting autoimmune disease have similar efficacy and toxicity rates from immune checkpoint inhibition: Netherlands’ experience. Read More
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation
Posted
January 20, 2020
Immune checkpoint inhibitor-induced inflammatory arthritis….. not as transient as you may think! Read More